Close
Nordic 9Nordic 9

CanSense (private company)

United Kingdom cansenseltd.com
See something wrong or missing? Let us know
Offices:Swansea
Industry:Health servicesPharma
Business model:B2B
CanSense is an accurate, rapid, non-invasive, blood diagnostic for the early detection of cancer.
Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 1.8M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to CanSense

Name Criteria
Iceland 3Z Pharmaceuticals
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
France ABC Transfer
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France AbolerIS Pharma
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Athera
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Sweden AttgeNO
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Denmark Oui
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Finland DelSiTech
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Ilya Pharma
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Spain Origo Biopharma
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Pharmanest
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top